Stavros G. Drakos
No Rating Available
(Learn About Our Rating System)

Stavros G. Drakos, MD, PhD, FACC

Languages spoken: English, Modern Greek

Clinical Locations

Primary Location

University of Utah Hospital

50 N Medical Dr
Salt Lake City , UT 84132
801-585-5122
Get Directions

University of Utah Hospital

Heart Transplant Clinic
50 N Medical Dr
Salt Lake City , UT 84132
801-585-5122
Get Directions

Veterans Administration Medical Center

500 S Foothill Blvd
Salt Lake City , UT 84148
801-584-1235
Get Directions
Show 1 more location(s)

University of Utah Hospital

Heart Failure Clinic
50 N Medical Dr
Salt Lake City , UT 84132
801-585-5122
Get Directions

Dr. Stavros George Drakos is a Professor of Medicine and the Co-Director of the Cardiovascular, Renal, and Metabolism Center (CRMC) at the University of Utah Health & School of Medicine. He is also the Co-Director of the Heart Failure & Transplant Section and the Medical Director of our institution's historic Mechanical Circulatory Support Program.

Dr. Drakos holds the H.A. & Edna Benning Presidential Endowed Chair and has published clinical studies in heart failure together with original scientific work generated in the laboratory which led to the establishment of the award-winning Utah Cardiac Recovery Program (UCAR). He served as the chairperson of the Clinical Integrative Cardiovascular and Hematological Sciences (CCHS) at the NIH and is a visiting professor in academic medical centers nationally and internationally. Dr. Drakos has mentored over the years several individuals who are now independent faculty in academic medical centers in the US and overseas.

CLINICAL INFO

Dr. Drakos is one of 27 cardiologists across the country being recognized by Forbes as an exemplary physician in the field of Cardiology (for more info click here).

Earlier in his career he completed advanced heart failure and transplant training at the U of Utah (2001-2003) and after returning to the U of Athens in Greece he played a pivotal role in starting the first Ventricular Assist Device (VAD) program in the country (2003-2008) in collaboration with Sir Magdi Yacoub's team, Harefield/Imperial College London. Six years later (2008) he was recruited back at the U of Utah and since then he has been on faculty at the Division of Cardiology.

What kind of patients Dr. Drakos sees?

Dr. Drakos’ clinical specialties include Heart Failure and Cardiomyopathies, Heart Transplantation and Mechanical Circulatory Support (MCS/VAD). He is licensed to practice medicine in the US and the EU. He currently receives patient referrals and consultations from several states. To schedule an appointment please call 801-585-5122. For 12 years in a row, University of Utah Health has been ranked in the top 10 for Health Care Quality among major university hospitals in the US: https://healthcare.utah.edu/quality/

ACADEMIC INFO

Dr. Drakos’ research interests are focused on cardiac recovery in the chronic heart failure (HF) setting and the acute setting (i. e. acute HF/cardiogenic shock). Dr Drakos' team is utilizing clinical and biological information derived from studies in humans and small or large animal HF models to understand and enhance myocardial recovery. Dr. Drakos' NIH-funded team is housed at the Nora Eccles Harrison Cardiovascular Research and Training Institute-CVRTI (Drakos Lab website). Original work generated by Dr. Drakos' team in the clinical arena and in his lab led to the establishment of the award-winning multidisciplinary Utah Cardiac Recovery Program-UCAR. To further advance the field of cardiac recovery Dr. Drakos is co-directing the annual international Utah Cardiac Recovery Symposium (UCARS) - for more info click here.

TRAINING:

1. Dr. Drakos started his medical training at the Univ. of Athens School of Medicine (most competitive academic institution in Greece: https://en.uoa.gr/ ) where he was admitted after scoring 3rd highest out of thousands pre-med students on the state boards. He received his Medical Degree (M.D.) with Honors and went on to acquire a Ph. D under the mentorship of John N. Nanas, MD/PhD, a prior trainee of the U of Utah (Thesis entitled: 'Pulsatile vs. non-pulsatile mechanical circulatory support in a porcine model of heart failure', Award: 'Top PhD Thesis of the Year, U of Athens')

2. Internal Medicine and General Cardiology Training: U of Athens (Mentors: John N. Nanas, MD/PhD).

3. Heart Failure/Transplant/MCS Fellowship: U of Utah, Intermountain Healthcare & Salt Lake VA Medical Center (Mentors: Dale G. Renlund, MD, and Elizabeth H. Hammond, MD).

4. Harefield-UK Athens-Greece Cardiac Recovery Program (H. A. R. P. ), (Mentor: Sir Magdi H. Yacoub, MD)

5. Cardiovascular Translational Research Fellowship: Molecular Medicine Program / Eccles Institute of Human Genetics, U of Utah (Mentor: Dean Y. Li, MD/PhD).

NOW HIRING - WHY IN THE ACADEMIC ENVIRONMENT OF UTAH:

From a historical perspective Dr. Drakos’ mentors, John Nanas, MD/PhD and Alex Kralios, MD/PhD, also came from the U of Athens and excelled here at the U of Utah in the 70's, 80's and 90's while working with Drs. Kolff ('father of artificial organs') and Moulopoulos (inventor of Intraaortic Balloon Pump - IABP). Inspired by the concept of using technology to replace biology they led important discoveries/patents and played a significant role in advancing the Mechanical Circulatory Support field through the pioneering of IABP, Paraaortic Counterpulsation (PULVAD) and the first Total Artificial Heart (TAH).

In a similarly inspiring academic environment Dr. Drakos is guiding his lab and clinical teams focused on using technology to understand and manipulate biology with the goal being myocardial recovery. For clinical or research job opportunities please contact stavros.drakos@hsc.utah.edu (please include your CV and potential referees).

For info regarding life in scenic Salt Lake City and Utah please visit: https://uofuhealth.utah.edu/living-in-utah and https://uofuhealth.utah.edu/why-utah

RESEARCH SUPPORT/FUNDING:

Dr. Drakos and his mentees have received over the years extensive extramural research funding and competitive scientific medical awards in the US and Europe from the NIH, AHA, Department of Veterans Affairs, European Union/EU Marie Curie, ISHLT, Doris Duke Foundation, Intermountain Research Medical Foundation, Leventis and Bodossakis Foundations and others.

Specialties

Board Certification

Board Certified in Cardiology (European Union and European Commission Board Certification)
European Society of Cardiology (Heart Failure Certification)

Dr. Stavros George Drakos is a Professor of Medicine and the Co-Director of the Cardiovascular, Renal, and Metabolism Center (CRMC) at the University of Utah Health & School of Medicine. He is also the Co-Director of the Heart Failure & Transplant Section and the Medical Director of our institution's historic Mechanical Circulatory Support Program.

Dr. Drakos holds the H.A. & Edna Benning Presidential Endowed Chair and has published clinical studies in heart failure together with original scientific work generated in the laboratory which led to the establishment of the award-winning Utah Cardiac Recovery Program (UCAR). He served as the chairperson of the Clinical Integrative Cardiovascular and Hematological Sciences (CCHS) at the NIH and is a visiting professor in academic medical centers nationally and internationally. Dr. Drakos has mentored over the years several individuals who are now independent faculty in academic medical centers in the US and overseas.

CLINICAL INFO

Dr. Drakos is one of 27 cardiologists across the country being recognized by Forbes as an exemplary physician in the field of Cardiology (for more info click here).

Earlier in his career he completed advanced heart failure and transplant training at the U of Utah (2001-2003) and after returning to the U of Athens in Greece he played a pivotal role in starting the first Ventricular Assist Device (VAD) program in the country (2003-2008) in collaboration with Sir Magdi Yacoub's team, Harefield/Imperial College London. Six years later (2008) he was recruited back at the U of Utah and since then he has been on faculty at the Division of Cardiology.

What kind of patients Dr. Drakos sees?

Dr. Drakos’ clinical specialties include Heart Failure and Cardiomyopathies, Heart Transplantation and Mechanical Circulatory Support (MCS/VAD). He is licensed to practice medicine in the US and the EU. He currently receives patient referrals and consultations from several states. To schedule an appointment please call 801-585-5122. For 12 years in a row, University of Utah Health has been ranked in the top 10 for Health Care Quality among major university hospitals in the US: https://healthcare.utah.edu/quality/

ACADEMIC INFO

Dr. Drakos’ research interests are focused on cardiac recovery in the chronic heart failure (HF) setting and the acute setting (i. e. acute HF/cardiogenic shock). Dr Drakos' team is utilizing clinical and biological information derived from studies in humans and small or large animal HF models to understand and enhance myocardial recovery. Dr. Drakos' NIH-funded team is housed at the Nora Eccles Harrison Cardiovascular Research and Training Institute-CVRTI (Drakos Lab website). Original work generated by Dr. Drakos' team in the clinical arena and in his lab led to the establishment of the award-winning multidisciplinary Utah Cardiac Recovery Program-UCAR. To further advance the field of cardiac recovery Dr. Drakos is co-directing the annual international Utah Cardiac Recovery Symposium (UCARS) - for more info click here.

TRAINING:

1. Dr. Drakos started his medical training at the Univ. of Athens School of Medicine (most competitive academic institution in Greece: https://en.uoa.gr/ ) where he was admitted after scoring 3rd highest out of thousands pre-med students on the state boards. He received his Medical Degree (M.D.) with Honors and went on to acquire a Ph. D under the mentorship of John N. Nanas, MD/PhD, a prior trainee of the U of Utah (Thesis entitled: 'Pulsatile vs. non-pulsatile mechanical circulatory support in a porcine model of heart failure', Award: 'Top PhD Thesis of the Year, U of Athens')

2. Internal Medicine and General Cardiology Training: U of Athens (Mentors: John N. Nanas, MD/PhD).

3. Heart Failure/Transplant/MCS Fellowship: U of Utah, Intermountain Healthcare & Salt Lake VA Medical Center (Mentors: Dale G. Renlund, MD, and Elizabeth H. Hammond, MD).

4. Harefield-UK Athens-Greece Cardiac Recovery Program (H. A. R. P. ), (Mentor: Sir Magdi H. Yacoub, MD)

5. Cardiovascular Translational Research Fellowship: Molecular Medicine Program / Eccles Institute of Human Genetics, U of Utah (Mentor: Dean Y. Li, MD/PhD).

NOW HIRING - WHY IN THE ACADEMIC ENVIRONMENT OF UTAH:

From a historical perspective Dr. Drakos’ mentors, John Nanas, MD/PhD and Alex Kralios, MD/PhD, also came from the U of Athens and excelled here at the U of Utah in the 70's, 80's and 90's while working with Drs. Kolff ('father of artificial organs') and Moulopoulos (inventor of Intraaortic Balloon Pump - IABP). Inspired by the concept of using technology to replace biology they led important discoveries/patents and played a significant role in advancing the Mechanical Circulatory Support field through the pioneering of IABP, Paraaortic Counterpulsation (PULVAD) and the first Total Artificial Heart (TAH).

In a similarly inspiring academic environment Dr. Drakos is guiding his lab and clinical teams focused on using technology to understand and manipulate biology with the goal being myocardial recovery. For clinical or research job opportunities please contact stavros.drakos@hsc.utah.edu (please include your CV and potential referees).

For info regarding life in scenic Salt Lake City and Utah please visit: https://uofuhealth.utah.edu/living-in-utah and https://uofuhealth.utah.edu/why-utah

RESEARCH SUPPORT/FUNDING:

Dr. Drakos and his mentees have received over the years extensive extramural research funding and competitive scientific medical awards in the US and Europe from the NIH, AHA, Department of Veterans Affairs, European Union/EU Marie Curie, ISHLT, Doris Duke Foundation, Intermountain Research Medical Foundation, Leventis and Bodossakis Foundations and others.

Board Certification and Academic Information

Academic Departments Internal Medicine -Professor
Academic Divisions Cardiovascular Medicine
Board Certification
Board Certified in Cardiology (European Union and European Commission Board Certification)
European Society of Cardiology (Heart Failure Certification)

Education history

Professional Medical Medicine, Summa Cum Laude - most competive academic institution in Greece and greater Balkan area - University of Athens M.D.
Doctoral Training Pulsatile vs. Non Pulsatile Mechanical Support in a Porcine Model of Heart Failure, Award Best 3 PhD Theses 2000-2005 ¿ Mentor: John Nanas, MD/PhD - University of Athens Ph.D.
Residency Internal Medicine - University of Athens Resident
Fellowship Advanced Heart Failure Fellowship - Director: Dale G. Renlund, MD - UTAH Cardiac Transplant Program - University of Utah Health; Intermountain Health; SLC VA Health Fellow
Fellowship Harefield Athens Recovery Program-HARP ¿ Directors: Sir Magdi Yacoub, MD & John Nanas, MD/PhD - Harefield Heart Sciences Center/Imperial College London & University of Athens, Greece Fellow
Fellowship Cardiovascular Translational Research Fellowship; Molecular Medicine Program- Director: Dean Y. Li, MD/PhD - University of Utah/ Eccles Institute of Human Genetics Fellow

Selected Publications

Journal Article

  1. Drakos SG, Papamichael CM, Alexopoulos GP, Anastasiou-Nana MI, Stathopoulos JV, Nanas JN (2003). Effects of high doses versus standard doses of enalapril on endothelial cell function in patients with chronic congestive heart failure secondary to idiopathic dilated or ischemic cardiomyopathy. Am J Cardiol, 91(7), 885-8.
  2. Drakos SG, Janicki L, Horne BD, Kfoury AG, Reid BB, Clayson S, Horton K, Haddad F, Li DY, Renlund DG, Fisher PW (2010). Risk factors predictive of right ventricular failure after left ventricular assist device implantation. Am J Cardiol, 105(7), 1030-5.
  3. Drakos SG, Kfoury AG, Long JW, Stringham JC, Fuller TC, Nelson KE, Campbell BK, Gilbert EM, Renlund DG (2006). Low-dose prophylactic intravenous immunoglobulin does not prevent HLA sensitization in left ventricular assist device recipients. Ann Thorac Surg, 82(3), 889-93.
  4. Drakos SG, Kfoury AG, Gilbert EM, Long JW, Stringham JC, Hammond EH, Jones KW, Bull DA, Hagan ME, Folsom JW, Horne BD, Renlund DG (2007). Multivariate predictors of heart transplantation outcomes in the era of chronic mechanical circulatory support. Ann Thorac Surg, 83(1), 62-7.
  5. Drakos SG, Terrovitis JV, Nanas JN, Charitos EI, Ntalianis AS, Malliaras KG, Diakos N, Koudoumas D, Theodoropoulos S, Yacoub MH, Anastasiou-Nana MI (2011). Reverse electrophysiologic remodeling after cardiac mechanical unloading for end-stage nonischemic cardiomyopathy. Ann Thorac Surg, 91(3), 764-9.
  6. Healy AH, Mason NO, Hammond ME, Reid BB, Clayson SE, Drakos SG, Kfoury AG, Patel AN, Bull DA, Budge D, Alharethi RA, Bader FM, Gilbert EM, Stehlik J, Selzman CH (2011). Allograft rejection in patients supported with continuous-flow left ventricular assist devices. Ann Thorac Surg, 92(5), 1601-7; discussion 1607.
  7. Healy AH, Baird BC, Drakos SG, Stehlik J, Selzman CH (2013). Impact of ventricular assist device complications on posttransplant survival: an analysis of the United network of organ sharing database. Ann Thorac Surg, 95(3), 870-5.
  8. Wozniak CJ, Stehlik J, Baird BC, McKellar SH, Song HK, Drakos SG, Selzman CH (2014). Ventricular assist devices or inotropic agents in status 1A patients? Survival analysis of the United Network of Organ Sharing database. Ann Thorac Surg, 97(4), 1364-71; discussion 1371-2.
  9. Selzman CH, Madden JL, Healy AH, McKellar SH, Koliopoulou A, Stehlik J, Drakos SG (2015). Bridge to removal: a paradigm shift for left ventricular assist device therapy. Ann Thorac Surg, 99(1), 360-7.
  10. Healy AH, Koliopoulou A, Drakos SG, McKellar SH, Stehlik J, Selzman CH (2015). Patient-controlled conditioning for left ventricular assist device-induced myocardial recovery. Ann Thorac Surg, 99(5), 1794-6.
  11. Pierrakos CN, Bonios MJ, Drakos SG, Charitos EI, Tsolakis EJ, Ntalianis A, Nanas SN, Charitos CE, Nanas JN, Terrovitis JV (2011). Mechanical assistance by intra-aortic balloon pump counterpulsation during reperfusion increases coronary blood flow and mitigates the no-reflow phenomenon: an experimental study. Artif Organs, 35(9), 867-74.
  12. Drakos SG, Kfoury AG, Long JW, Stringham JC, Gilbert EM, Moore SA, Campbell BK, Nelson KE, Horne BD, Renlund DG (2006). Effect of mechanical circulatory support on outcomes after heart transplantation. J Heart Lung Transplant, 25(1), 22-8.
  13. Terrovitis JV, Anastasiou-Nana MI, Alexopoulos GP, Tsolakis EJ, Margari ZJ, Drakos SG, Tsagalou EP, Papazoglou P, Efentakis S, Nanas JN (2006). Prevalence and prognostic significance of anemia in patients with congestive heart failure treated with standard vs high doses of enalapril. J Heart Lung Transplant, 25(3), 333-8.
  14. Drakos SG, Kfoury AG, Gilbert EM, Horne BD, Long JW, Stringham JC, Campbell BA, Renlund DG (2007). Effect of reversible pulmonary hypertension on outcomes after heart transplantation. J Heart Lung Transplant, 26(4), 319-23.
  15. Kfoury AG, Hammond ME, Snow GL, Drakos SG, Stehlik J, Fisher PW, Reid BB, Everitt MD, Bader FM, Renlund DG (2009). Cardiovascular mortality among heart transplant recipients with asymptomatic antibody-mediated or stable mixed cellular and antibody-mediated rejection. J Heart Lung Transplant, 28(8), 781-4.
  16. Drakos SG, Kfoury AG, Kotter JR, Reid BB, Clayson SE, Selzman CH, Stehlik J, Fisher PW, Merida M 3rd, Eckels DD, Brunisholz K, Horne BD, Stoker S, Li DY, Renlund DG (2009). Prior human leukocyte antigen-allosensitization and left ventricular assist device type affect degree of post-implantation human leukocyte antigen-allosensitization. J Heart Lung Transplant, 28(8), 838-42.
  17. Dimopoulos SK, Drakos SG, Terrovitis JV, Tzanis GS, Nanas SN (2010). Improvement in respiratory muscle dysfunction with continuous-flow left ventricular assist devices. J Heart Lung Transplant, 29(8), 906-8.
  18. Singhal AK, Drakos SG, Kfoury AG, Horne BD, Verma DR, Stehlik J (2010). Prolonged allograft ischemic time is not associated with higher incidence of antibody-mediated rejection. J Heart Lung Transplant, 29(10), 1198-200.
  19. Verma DR, Drakos SG, Stehlik J, Horne BD, Kfoury AG (2010). Effect of preservation solution choice on antibody-mediated rejection after heart transplantation. J Heart Lung Transplant, 29(11), 1314-5.
  20. Brush S, Budge D, Alharethi R, McCormick AJ, MacPherson JE, Reid BB, Ledford ID, Smith HK, Stoker S, Clayson SE, Doty JR, Caine WT, Drakos S, Kfoury AG (2010). End-of-life decision making and implementation in recipients of a destination left ventricular assist device. J Heart Lung Transplant, 29(12), 1337-41.
  21. Nativi JN, Drakos SG, Kucheryavaya AY, Edwards LB, Selzman CH, Taylor DO, Hertz MI, Kfoury AG, Stehlik J (2011). Changing outcomes in patients bridged to heart transplantation with continuous- versus pulsatile-flow ventricular assist devices: an analysis of the registry of the International Society for Heart and Lung Transplantation. J Heart Lung Transplant, 30(8), 854-61.
  22. Kfoury AG, Snow GL, Budge D, Alharethi RA, Stehlik J, Everitt MD, Miller DV, Drakos SG, Reid BB, Revelo MP, Gilbert EM, Selzman CH, Bader FM, Connelly JJ, Hammond ME (2012). A longitudinal study of the course of asymptomatic antibody-mediated rejection in heart transplantation. J Heart Lung Transplant, 31(1), 46-51.
  23. Healy AH, Stehlik J, Edwards LB, McKellar SH, Drakos SG, Selzman CH (2016). Predictors of 30-day post-transplant mortality in patients bridged to transplantation with continuous-flow left ventricular assist devices--An analysis of the International Society for Heart and Lung Transplantation Transplant Registry. J Heart Lung Transplant, 35(1), 34-39.
  24. Drakos SG, Mehra MR (2016). Clinical myocardial recovery during long-term mechanical support in advanced heart failure: insights into moving the field forward. The Journal of heart and lung transplantation, 35(4), 413-20.
  25. Yin MY, Wever-Pinzon O, Mehra MR, Selzman CH, Toll AE, Cherikh WS, Nativi-Nicolau J, Fang JC, Kfoury AG, Gilbert EM, Kemeyou L, McKellar SH, Koliopoulou A, Vaduganathan M, Drakos SG, Stehlik (2019). Post-transplant outcome in patients bridged to transplant with temporary mechanical circulatory support devices. The Journal of heart and lung transplantation, 38(8), 858-869.
  26. Kfoury AG, Miller DV, Snow GL, Afshar K, Stehlik J, Drakos SG, Budge D, Fang JC, Revelo MP, Alharethi RA, Gilbert EM, Caine WT, McKellar S, Molina KM, Hammond ME (2016). Mixed cellular and antibody-mediated rejection in heart transplantation: In-depth pathologic and clinical observations. The Journal of heart and lung transplantation, 35(3), 335-341.
  27. Bunsawat K, Ratchford SM, Alpenglow JK, Park SH, Jarrett CL, Stehlik J, Drakos SG, Richardson RS, Wray D (2020). Chronic antioxidant administration restores macrovascular function in patients with heart failure with reduced ejection fraction. Experimental physiology, 105(8), 1384-1395.
  28. Strüber M, Sander K, Lahpor J, Ahn H, Litzler PY, Drakos SG, Musumeci F, Schlensak C, Friedrich I, Gustafsson R, Oertel F, Leprince (2008). HeartMate II left ventricular assist device; early European experience. European journal of cardio-thoracic surgery, 34(2), 289-94.
  29. Abdullah OM, Drakos SG, Diakos NA, Wever-Pinzon O, Kfoury AG, Stehlik J, Selzman CH, Reid BB, Brunisholz K, Verma DR, Myrick C, Sachse FB, Li DY, Hsu E (2014). Characterization of diffuse fibrosis in the failing human heart via diffusion tensor imaging and quantitative histological validation. NMR in biomedicine, 27(11), 1378-86.
  30. Wachter SB, McCandless SP, Gilbert EM, Stoddard GJ, Kfoury AG, Reid BB, McKellar SH, Nativi-Nicolau J, Saidi A, Barney J, McCreath L, Koliopoulou A, Wright SE, Fang JC, Stehlik J, Selzman CH, Drakos S (2015). Elevated resting heart rate in heart transplant recipients: innocent bystander or adverse prognostic indicator?. Clinical transplantation, 29(9), 829-34.
  31. Drakos SG, Charitos CE, Ntalianis A, Terrovitis JV, Siafakas KX, Dolou P, Pierrakos C, Charitos E, Karelas J, Nanas J (2005). Comparison of pulsatile with nonpulsatile mechanical support in a porcine model of profound cardiogenic shock. ASAIO journal (American Society for Artificial Internal Organs, 51(1), 26-9.
  32. Ntalianis AS, Drakos SG, Charitos C, Dolou P, Pierrakos CN, Terrovitis JV, Papaioannou T, Charitos E, Nanas J (2008). Effects of intra-aortic balloon pump versus centrifugal pump on myocardial energetics and systemic circulation in a porcine model of rapidly worsening acute heart failure. ASAIO journal (American Society for Artificial Internal Organs, 54(6), 600-5.
  33. Madden JL, Drakos SG, Stehlik J, McKellar SH, Rondina MT, Weyrich AS, Selzman C (2014). Baseline red blood cell osmotic fragility does not predict the degree of post-LVAD hemolysis. ASAIO journal (American Society for Artificial Internal Organs, 60(5), 524-8.
  34. Hydren JR, Kithas AC, Park SH, Wever-Pinzon O, Selzman CH, Perry W, Vargas CAS, Stehlik J, Drakos SG, Richardson R (2020). Targeting Peripheral Vascular Pulsatility in Heart Failure Patients with Continuous-Flow Left Ventricular Assist Devices: The Impact of Pump Speed. ASAIO journal (American Society for Artificial Internal Organs, 66(3), 291-299.
  35. Money JE, Al Danaf J, Nelson M, Mckellar SH, Drakos SG, Kemeyou (2020). Loss of Pulsatility: Another Cause of Syncope in Patients with Left Ventricular Assist Devices. ASAIO journal (American Society for Artificial Internal Organs, 66(10), e128-e130.
  36. Hydren JR, Cornwell WK 3rd, Richardson RS, Drakos S (2020). Exercise Capacity in Mechanically Supported Advanced Heart Failure Patients: It Is All About the Beat. ASAIO journal (American Society for Artificial Internal Organs, 66(4), 339-342.
  37. Money JE, Al Danaf J, Nelson M, Mckellar SH, Drakos SG, Kemeyou (2020). Loss of Pulsatility: Another Cause of Syncope in Patients with Left Ventricular Assist Devices. ASAIO journal (American Society for Artificial Internal Organs,
  38. Lobo AS, Sandoval Y, Henriques JP, Drakos SG, Taleb I, Bagai J, Cohen MG, Chatzizisis YS, Sun B, Hryniewicz K, Eckman PM, Thiele H, Brilakis E (2020). Cardiogenic Shock Management: International Survey of Contemporary Practices. The Journal of invasive cardiology, 32(10), 371-374.
  39. Drakos SG, Kfoury AG, Selzman CH, Verma DR, Nanas JN, Li DY, Stehlik (2011). Left ventricular assist device unloading effects on myocardial structure and function: current status of the field and call for action. Current opinion in cardiology, 26(3), 245-55.
  40. Drakos SG, Anastasiou-Nana MI, Terrovitis JV, Tsagalou EP, Kanakakis J, Ntalianis A, Lazaris N, Maroulidis G, Venetsanakos J, Bonios M, Nanas J (2008). Intra-aortic balloon counterpulsation and delayed revascularization for myocardial infarction and shock in the absence of primary angioplasty: a treatment strategy with or without thrombolysis?. Coronary artery disease, 19(7), 521-6.
  41. Nanas JN, Tsolakis E, Terrovitis JV, Eleftheriou A, Drakos SG, Dalianis A, Charitos C (2004). Moderate systemic hypotension during reperfusion reduces the coronary blood flow and increases the size of myocardial infarction in pigs. Chest, 125(4), 1492-9.
  42. Drakos SG, Kfoury AG, Stehlik J, Selzman CH, Reid BB, Terrovitis JV, Nanas JN, Li D (2012). Bridge to recovery: understanding the disconnect between clinical and biological outcomes. Circulation, 126(2), 230-41.
  43. Wever-Pinzon O, Drakos SG, Kfoury AG, Nativi JN, Gilbert EM, Everitt M, Alharethi R, Brunisholz K, Bader FM, Li DY, Selzman CH, Stehlik (2013). Morbidity and mortality in heart transplant candidates supported with mechanical circulatory support: is reappraisal of the current United network for organ sharing thoracic organ allocation policy justified?. Circulation, 127(4), 452-62.
  44. Birks EJ, Drakos SG, Patel SR, Lowes BD, Selzman CH, Starling RC, Trivedi J, Slaughter MS, Alturi P, Goldstein D, Maybaum S, Um JY, Margulies KB, Stehlik J, Cunningham C, Farrar DJ, Rame J (2020). Prospective Multicenter Study of Myocardial Recovery Using Left Ventricular Assist Devices (RESTAGE-HF [Remission from Stage D Heart Failure]): Medium-Term and Primary End Point Results. Circulation, 142(21), 2016-2028.
  45. Badolia R, Ramadurai DKA, Abel ED, Ferrin P, Taleb I, Shankar TS, Krokidi AT, Navankasattusas S, McKellar SH, Yin M, Kfoury AG, Wever-Pinzon O, Fang JC, Selzman CH, Chaudhuri D, Rutter J, Drakos S (2020). The Role of Nonglycolytic Glucose Metabolism in Myocardial Recovery Upon Mechanical Unloading and Circulatory Support in Chronic Heart Failure. Circulation, 142(3), 259-274.
  46. Drakos SG, Bonios MJ, Anastasiou-Nana MI, Tsagalou EP, Terrovitis JV, Kaldara E, Maroulidis G, Nanas SN, Kanakakis J, Nanas J (2009). Long-term survival and outcomes after hospitalization for acute myocardial infarction complicated by cardiogenic shock. Clinical cardiology, 32(8), E4-8.
  47. Papazachou O, Anastasiou-Nana M, Sakellariou D, Tassiou A, Dimopoulos S, Venetsanakos J, Maroulidis G, Drakos S, Roussos C, Nanas (2007). Pulmonary function at peak exercise in patients with chronic heart failure. International journal of cardiology, 118(1), 28-35.
  48. Bonios MJ, Pierrakos CN, Argiriou M, Dalianis A, Terrovitis JV, Dolou P, Drakos SG, Koudoumas D, Charitos CE, Anastasiou-Nana M (2010). Increase in coronary blood flow by intra-aortic balloon counterpulsation in a porcine model of myocardial reperfusion. International journal of cardiology, 138(3), 253-60.
  49. Bonios MJ, Terrovitis JV, Drakos SG, Katsaros F, Pantsios C, Nanas SN, Kanakakis J, Alexopoulos G, Toumanidis S, Anastasiou-Nana M, Nanas J (2012). Comparison of three different regimens of intermittent inotrope infusions for end stage heart failure. International journal of cardiology, 159(3), 225-9.
  50. Drakos SG, Anastasiou'Nana M, Nanas J (2001). Exacerbation of variant angina by metoprolol resulting in syncope due to transient atrioventricular block. International journal of cardiology, 82, 83-85.
  51. Nanas JN, Matsouka C, Karageorgopoulos D, Leonti A, Tsolakis E, Drakos SG, Tsagalou EP, Maroulidis GD, Alexopoulos GP, Kanakakis JE, Anastasiou-Nana M (2006). Etiology of anemia in patients with advanced heart failure. Journal of the American College of Cardiology, 48(12), 2485-9.
  52. Tsagalou EP, Anastasiou-Nana M, Agapitos E, Gika A, Drakos SG, Terrovitis JV, Ntalianis A, Nanas J (2008). Depressed coronary flow reserve is associated with decreased myocardial capillary density in patients with heart failure due to idiopathic dilated cardiomyopathy. Journal of the American College of Cardiology, 52(17), 1391-8.
  53. Drakos SG, Kfoury AG, Hammond EH, Reid BB, Revelo MP, Rasmusson BY, Whitehead KJ, Salama ME, Selzman CH, Stehlik J, Clayson SE, Bristow MR, Renlund DG, Li D (2010). Impact of mechanical unloading on microvasculature and associated central remodeling features of the failing human heart. Journal of the American College of Cardiology, 56(5), 382-91.
  54. Drakos SG, Wever-Pinzon O, Selzman CH, Gilbert EM, Alharethi R, Reid BB, Saidi A, Diakos NA, Stoker S, Davis ES, Movsesian M, Li DY, Stehlik J, Kfoury AG, UCAR (Utah Cardiac Recovery Program) Investigators (2013). Magnitude and time course of changes induced by continuous-flow left ventricular assist device unloading in chronic heart failure: insights into cardiac recovery. Journal of the American College of Cardiology, 61(19), 1985-94.
  55. Diakos NA, Selzman CH, Sachse FB, Stehlik J, Kfoury AG, Wever-Pinzon O, Catino A, Alharethi R, Reid BB, Miller DV, Salama M, Zaitsev AV, Shibayama J, Li H, Fang JC, Li DY, Drakos S (2014). Myocardial atrophy and chronic mechanical unloading of the failing human heart: implications for cardiac assist device-induced myocardial recovery. Journal of the American College of Cardiology, 64(15), 1602-12.
  56. Wever-Pinzon O, Drakos SG, McKellar SH, Horne BD, Caine WT, Kfoury AG, Li DY, Fang JC, Stehlik J, Selzman C (2016). Cardiac Recovery During Long-Term Left Ventricular Assist Device Support. Journal of the American College of Cardiology, 68(14), 1540-53.
  57. Wever-Pinzon J, Selzman CH, Stoddard G, Wever-Pinzon O, Catino A, Kfoury AG, Diakos NA, Reid BB, McKellar S, Bonios M, Koliopoulou A, Budge D, Kelkhoff A, Stehlik J, Fang JC, Drakos S (2016). Impact of Ischemic Heart Failure Etiology on Cardiac Recovery During Mechanical Unloading. Journal of the American College of Cardiology, 68(16), 1741-1752.
  58. Omar Wever-Pinzon, Jorge Romero, Iosif Kelesidis, James Wever-Pinzon, Carlos Manrique, Deborah Budge, Drakos SG, Ileana Pina, Abdallah G. Kfoury, Mario J. Garcia, Josef Stehli (2014). Coronary Computed Tomography Angiography for the Detection of Cardiac Allograft Vasculopathy: A Meta-Analysis of Prospective Trials ONLINE FIRST. Journal of the American College of Cardiology,
  59. Wever-Pinzon O, Kfoury AG, Selzman CH, Li DY, Drakos S (2013). Left ventricular assist devices in chronic heart failure: more questions than answers?. Journal of the American College of Cardiology, 62(23), 2257-8.
  60. Wever-Pinzon O, Romero J, Kelesidis I, Wever-Pinzon J, Manrique C, Budge D, Drakos SG, Piña IL, Kfoury AG, Garcia MJ, Stehlik (2014). Coronary computed tomography angiography for the detection of cardiac allograft vasculopathy: a meta-analysis of prospective trials. Journal of the American College of Cardiology, 63(19), 1992-2004.
  61. Chan AC, Drakos SG, Ruiz OE, Smith AC, Gibson CC, Ling J, Passi SF, Stratman AN, Sacharidou A, Revelo MP, Grossmann AH, Diakos NA, Davis GE, Metzstein MM, Whitehead KJ, Li D (2011). Mutations in 2 distinct genetic pathways result in cerebral cavernous malformations in mice. The Journal of clinical investigation, 121(5), 1871-81.
  62. Frech TM, Revelo MP, Drakos SG, Murtaugh MA, Markewitz BA, Sawitzke AD, Li D (2012). Vascular leak is a central feature in the pathogenesis of systemic sclerosis. The Journal of rheumatology, 39(7), 1385-91.
  63. Drakos SG, Kanakakis JV, Nanas S, Bonios M, Kaldara E, Katsaros F, Pantsios C, Nanas J (2009). Intermittent inotropic infusions combined with prophylactic oral amiodarone for patients with decompensated end-stage heart failure. Journal of cardiovascular pharmacology, 53(2), 157-61.
  64. Hickman AW, Lonardo NW, Mone MC, Presson AP, Zhang C, Barton RG, Selzman CH, Drakos SG, Koliopoulou A, McKellar S (2019). Acid Suppression to Prevent Gastrointestinal Bleeding in Patients With Ventricular Assist Devices. The Journal of surgical research, 234, 96-102.
  65. Drakos SG, Stringham JC, Long JW, Gilbert EM, Fuller TC, Campbell BK, Horne BD, Hagan ME, Nelson KE, Lindblom JM, Meldrum PA, Carlson JF, Moore SA, Kfoury AG, Renlund D (2007). Prevalence and risks of allosensitization in HeartMate left ventricular assist device recipients: the impact of leukofiltered cellular blood product transfusions. The Journal of thoracic and cardiovascular surgery, 133(6), 1612-9.
  66. Bull DA, Reid BB, Selzman CH, Mesley R, Drakos S, Clayson S, Stoddard G, Gilbert E, Stehlik J, Bader F, Kfoury A, Budge D, Eckels DD, Fuller A, Renlund D, Patel A (2010). The impact of bridge-to-transplant ventricular assist device support on survival after cardiac transplantation. The Journal of thoracic and cardiovascular surgery, 140(1), 169-73.
  67. Wozniak CJ, Baird BC, Stehlik J, Drakos SG, Bull DA, Patel AN, Selzman C (2012). Improved survival in heart transplant patients living at high altitude. The Journal of thoracic and cardiovascular surgery, 143(3), 735-741.e1.
  68. Hong K, Jeong EK, Wall TS, Drakos SG, Kim (2015). Wideband arrhythmia-Insensitive-rapid (AIR) pulse sequence for cardiac T1 mapping without image artifacts induced by an implantable-cardioverter-defibrillator. Magnetic resonance in medicine, 74(2), 336-45.
  69. Wever-Pinzon O, Stehlik J, Kfoury AG, Terrovitis JV, Diakos NA, Charitos C, Li DY, Drakos S (2012). Ventricular assist devices: pharmacological aspects of a mechanical therapy. Pharmacology & therapeutics, 134(2), 189-99.
  70. Anastasiou-Nana MI, Tsagalou EP, Charitos C, Siafakas KX, Drakos S, Terrovitis JV, Ntalianis A, Doufas A, Mavrikakis J, Nanas J (2005). Effects of transient myocardial ischemia on the ventricular defibrillation threshold. Pacing and clinical electrophysiology, 28(2), 97-101.
  71. Dimopoulos S, Diakos N, Tseliou E, Tasoulis A, Mpouchla A, Manetos C, Katsaros L, Drakos S, Terrovitis J, Nanas (2011). Chronotropic incompetence and abnormal heart rate recovery early after left ventricular assist device implantation. Pacing and clinical electrophysiology, 34(12), 1607-14.
  72. Tsagalou EP, Anastasiou-Nana MI, Charitos CE, Siafakas CX, Drakos SG, Ntalianis A, Terrovitis JV, Mavrikakis EM, Doufas A, Nanas J (2004). Time course of fibrillation and defibrillation thresholds after an intravenous bolus of amiodarone--an experimental study. Resuscitation, 61(1), 83-9.
  73. Anastasiou-Nana MI, Tsagalou EP, Mavrikakis EM, Siafakas KX, Tsolakis EJ, Drakos SG, Dalianis A, Karelas J, Terrovitis JV, Nanas J (2005). Myocardial ischaemic preconditioning in the pig has no effect on the ventricular fibrillation and defibrillation thresholds. Resuscitation, 64(3), 373-6.
  74. Tasoulis A, Papazachou O, Dimopoulos S, Gerovasili V, Karatzanos E, Kyprianou T, Drakos S, Anastasiou-Nana M, Roussos C, Nanas (2010). Effects of interval exercise training on respiratory drive in patients with chronic heart failure. Respiratory medicine, 104(10), 1557-65.
  75. Frech T, De Domenico I, Murtaugh MA, Revelo MP, Li DY, Sawitzke AD, Drakos S (2014). Autophagy is a key feature in the pathogenesis of scytemic sclerosis. Rheumatology international, 34(3), 435-439.
  76. Singhal AK, Sheng X, Drakos SG, Stehlik (2009). Impact of donor cause of death on transplant outcomes: UNOS registry analysis. Transplantation proceedings, 41(9), 3539-44.
  77. Kotter JR, Drakos SG, Horne BD, Hammond EH, Stehlik J, Bull DA, Reid BB, Gilbert EM, Everitt M, Alharethi R, Budge D, Verma DR, Li DY, Kfoury A (2010). Effect of blood product transfusion-induced tolerance on incidence of cardiac allograft rejection. Transplantation proceedings, 42(7), 2687-92.
  78. Whitehead KJ, Chan AC, Navankasattusas S, Koh W, London NR, Ling J, Mayo AH, Drakos SG, Jones CA, Zhu W, Marchuk DA, Davis GE, Li D (2009). The cerebral cavernous malformation signaling pathway promotes vascular integrity via Rho GTPases. Nature medicine, 15(2), 177-84.
  79. Drakos SG, Pagani FD, Lundberg MS, Baldwin J (2017). Advancing the Science of Myocardial Recovery With Mechanical Circulatory Support: A Working Group of the National, Heart, Lung and Blood Institute. Journal of cardiac failure, 23(5), 416-421.
  80. Kanakakis J, Nanas JN, Tsagalou EP, Maroulidis GD, Drakos SG, Ntalianis AS, Tzoumele P, Skoumbourdis E, Charbis P, Rokas S, Anastasiou-Nana (2009). Multicenter randomized trial of facilitated percutaneous coronary intervention with low-dose tenecteplase in patients with acute myocardial infarction: the Athens PCI trial. Catheterization and cardiovascular interventions, 74(3), 398-405.
  81. Revelo MP, Miller DV, Stehlik J, Brunisholz K, Drakos S, Gilbert EM, Everitt M, Budge D, Alharethi R, Snow G, Hammond EH, Kfoury A (2012). Longitudinal evaluation of microvessel density in survivors vs. nonsurvivors of cardiac pathologic antibody-mediated rejection. Cardiovascular pathology, 21(6), 445-54.
  82. Nanas S, Nanas J, Kassiotis C, Nikolaou C, Tsagalou E, Sakellariou D, Terovitis I, Papazachou O, Drakos S, Papamichalopoulos A, Roussos (2001). Early recovery of oxygen kinetics after submaximal exercise test predicts functional capacity in patients with chronic heart failure. European journal of heart failure, 3(6), 685-92.
  83. Nanas SN, Nanas JN, Sakellariou DCh, Dimopoulos SK, Drakos SG, Kapsimalakou SG, Mpatziou CA, Papazachou OG, Dalianis AS, Anastasiou-Nana MI, Roussos (2006). VE/VCO2 slope is associated with abnormal resting haemodynamics and is a predictor of long-term survival in chronic heart failure. European journal of heart failure, 8(4), 420-7.
  84. Drakos SG, Kfoury AG, Long JW, Stringham JC, Gilbert EM, Horne BD, Hagan MB, Nelson K, Renlund D (2007). Similar transplantation outcomes in patients bridged with cardiac assist devices for acute cardiogenic shock versus chronic heart failure. European journal of heart failure, 9(8), 845-9.
  85. Park SY, Gifford JR, Andtbacka RH, Trinity JD, Hyngstrom JR, Garten RS, Diakos NA, Ives SJ, Dela F, Larsen S, Drakos S, Richardson R (2014). Cardiac, skeletal, and smooth muscle mitochondrial respiration: are all mitochondria created equal?. American journal of physiology. Heart and circulatory physiology, 307(3), H346-52.
  86. Frey C, Koliopoulou AG, Montenont E, Tolley ND, Javan H, McKellar SH, Drakos SG, Selzman CH, Rondina M (2020). Longitudinal assessment of the platelet transcriptome in advanced heart failure patients following mechanical unloading. Platelets, 31(7), 952-959.
  87. Wever Pinzon O, Stoddard G, Drakos SG, Gilbert EM, Nativi JN, Budge D, Bader F, Alharethi R, Reid B, Selzman CH, Everitt MD, Kfoury AG, Stehlik (2011). Impact of donor left ventricular hypertrophy on survival after heart transplant. American journal of transplantation, 11(12), 2755-61.
  88. Dimopoulos S, Anastasiou-Nana M, Sakellariou D, Drakos SG, Kapsimalakou S, Maroulidis G, Roditis P, Roussos C, Nanas (2006). Effects of exercise rehabilitation program on heart rate recovery in patients with chronic heart failure. European journal of cardiovascular prevention and rehabilitation, 13(1), 67-73.
  89. Drakos SG, Charitos EI, Nanas SN, Nanas J (2007). Ventricular-assist devices for the treatment of chronic heart failure. Expert review of cardiovascular therapy, 5(3), 571-84.
  90. Taleb I, Wever-Pinzon J, Wang W, Koliopoulou A, Dranow E, Yu T, Yin L, McKellar SH, Stehlik J, Fang JC, Wever-Pinzon O, Selzman CH, Drakos S (2020). Outcomes of Asian-Americans Implanted With Left Ventricular Assist Devices: An Interagency Registry for Mechanically Assisted Circulatory Support (INTERMACS) Analysis. Heart, lung & circulation, 29(8), 1226-1233.
  91. Tsagalou EP, Kanakakis J, Anastasiou-Nana MI, Drakos SG, Ntalianis AS, Malliaras K, Lazaris N, Katsaros F, Nanas J (2009). Hemodynamic effects of levosimendan in acute myocardial infarction complicated by cardiogenic shock and high systemic vascular resistance. Acute cardiac care, 11(2), 99-106.
  92. Oka SI, Sabry AD, Horiuchi AK, Cawley KM, O'Very SA, Zaitsev MA, Shankar TS, Byun J, Mukai R, Xu X, Torres NS, Kumar A, Yazawa M, Ling J, Taleb I, Saijoh Y, Drakos SG, Sadoshima J, Warren J (2020). Perm1 regulates cardiac energetics as a downstream target of the histone methyltransferase Smyd1. PloS one, 15(6), e0234913.
  93. Ziras N, Rozakou A, Skoura S, Drakos S, Venetsanou V, Tsiggalakis D, Fragaki Μ, Giannakakis T, Athanassiou (2001). Soluble transferrin receptor: An early predicting index of response to epoetin alfa treatment for the prophylaxis of chemotherapy-induced anemia in patients with solid tumors. Journal of B.U.ON., 6, 67-73.
  94. Gerovasili V, Drakos S, Kravari M, Malliaras K, Karatzanos E, Dimopoulos S, Tasoulis A, Anastasiou-Nana M, Roussos C, Nanas (2009). Physical exercise improves the peripheral microcirculation of patients with chronic heart failure. Journal of cardiopulmonary rehabilitation and prevention, 29(6), 385-91.
  95. Malliaras KG, Terrovitis JV, Drakos SG, Nanas J (2009). Reverse cardiac remodeling enabled by mechanical unloading of the left ventricle. Journal of cardiovascular translational research, 2(1), 114-25.
  96. Stavrakis S, Terrovitis J, Tsolakis E, Drakos S, Dalianis A, Bonios M, Koudoumas D, Malliaras K, Nanas (2011). Relationship between retrograde coronary blood flow and the extent of no-reflow and infarct size in a porcine ischemia-reperfusion model. Journal of cardiovascular translational research, 4(1), 99-105.
  97. Drakos SG, Athanasoulis T, Malliaras KG, Terrovitis JV, Diakos N, Koudoumas D, Ntalianis AS, Theodoropoulos SP, Yacoub MH, Nanas J (2010). Myocardial sympathetic innervation and long-term left ventricular mechanical unloading. JACC. Cardiovascular imaging, 3(1), 64-70.
  98. Wever-Pinzon O, Selzman CH, Drakos SG, Saidi A, Stoddard GJ, Gilbert EM, Labedi M, Reid BB, Davis ES, Kfoury AG, Li DY, Stehlik J, Bader (2013). Pulsatility and the risk of nonsurgical bleeding in patients supported with the continuous-flow left ventricular assist device HeartMate II. Circulation. Heart failure, 6(3), 517-26.
  99. Iosif Taleb , Antigone G. Koliopoulou , Anwar Tandar , Stephen H. McKellar , Joseph E. Tonna , Jose Nativi-Nicolau , Miguel Alvarez Villela , Frederick Welt , Josef Stehlik , Edward M. Gilbert, Omar Wever-Pinzon , Jack H. Morshedzadeh , Elizabeth Dranow , Craig H. Selzman , James C. Fang , Stavros G. Drako (2019). Shock Team Approach in Refractory Cardiogenic Shock Requiring Short-Term Mechanical Circulatory Support. Circulation. Heart failure, 140(1), 98-100.
  100. Symons JD, Deeter L, Deeter N, Bonn T, Cho JM, Ferrin P, McCreath L, Diakos NA, Taleb I, Alharethi R, McKellar S, Wever-Pinzon O, Navankasattusas S, Selzman CH, Fang JC, Drakos S (2019). Effect of Continuous-Flow Left Ventricular Assist Device Support on Coronary Artery Endothelial Function in Ischemic and Nonischemic Cardiomyopathy. Circulation. Heart failure, 12(8), e006085.
  101. Uriel N, Burkhoff D, Rich JD, Drakos SG, Teuteberg JJ, Imamura T, Rodgers D, Raikhelkar J, Vorovich EE, Selzman CH, Kim G, Sayer (2019). Impact of Hemodynamic Ramp Test-Guided HVAD Speed and Medication Adjustments on Clinical Outcomes. Circulation. Heart failure, 12(4), e006067.
  102. Ko B, Drakos SG, Ibrahim H, Kang TS, Thodou A, Bonios M, Taleb I, Welt F (2020). Percutaneous Mechanical Unloading Simultaneously With Reperfusion Induces Increased Myocardial Salvage in Experimental Acute Myocardial Infarction. Circulation. Heart failure, 13(1), e005893.
  103. Witman MA, Garten RS, Gifford JR, Groot HJ, Trinity JD, Stehlik J, Nativi JN, Selzman CH, Drakos SG, Richardson R (2015). Further Peripheral Vascular Dysfunction in Heart Failure Patients With a Continuous-Flow Left Ventricular Assist Device: The Role of Pulsatility. JACC. Heart failure, 3(9), 703-11.
  104. Yin MY, Strege J, Gilbert EM, Stehlik J, McKellar SH, Elmer A, Anderson T, Aljuaid M, Nativi-Nicolau J, Koliopoulou AG, Davis E, Fang JC, Drakos SG, Selzman CH, Wever-Pinzon (2020). Impact of Shared Care in Remote Areas for Patients With Left Ventricular Assist Devices. JACC. Heart failure, 8(4), 302-312.
  105. Riehle C, Weatherford ET, Wende AR, Jaishy BP, Seei AW, McCarty NS, Rech M, Shi Q, Reddy GR, Kutschke WJ, Oliveira K, Pires KM, Anderson JC, Diakos NA, Weiss RM, White MF, Drakos SG, Xiang YK, Abel E (2020). Insulin receptor substrates differentially exacerbate insulin-mediated left ventricular remodeling. JCI insight, 5(6),
  106. Diakos NA, Navankasattusas S, Abel ED, Rutter J, McCreath L, Ferrin P, McKellar SH, Richardson R, Deberardinis R, Kfoury AG, Selzman CH, Stehlik J, Fang JC, Li DY, Drakos S (2016). Evidence of glycolysis upregulation and pyruvate mitochondrial oxidation mismatch during mechanical unloading of the failing human heart: implications for cardiac reloading and conditioning. JACC. Basic to translational science,
  107. Drakos SG, Pagani FD, Lundberg MS, Baldwin J (2017). Advancing the Science of Myocardial Recovery With Mechanical Circulatory Support: A Working Group of the National, Heart, Lung, and Blood Institute. JACC. Basic to translational science, 2(3), 335-340.
  108. Kravari M, Vasileiadis I, Gerovasili V, Karatzanos E, Tasoulis A, Kalligras K, Drakos SG, Dimopoulos S, Anastasiou-Nana M, Nanas (2008). Effects of a 3-month rehabilitation program on muscle oxygenation in congestive heart failure patients as assessed by NIRS.
  109. Maron BA, Wang RS, Shevtsov S, Drakos SG, Arons E, Wever-Pinzon O, Huggins GS, Samokhin AO, Oldham WM, Aguib Y, Yacoub MH, Rowin EJ, Maron BJ, Maron MS, Loscalzo (2021). Individualized interactomes for network-based precision medicine in hypertrophic cardiomyopathy with implications for other clinical pathophenotypes. Nature communications, 12(1), 873.
  110. Hoffman M, Palioura D, Kyriazis ID, Cimini M, Badolia R, Rajan S, Gao E, Nikolaidis N, Schulze PC, Goldberg IJ, Kishore R, Yang VW, Bannister TD, Bialkowska AB, Selzman CH, Drakos SG, Drosatos (2021). Cardiomyocyte Krüppel-Like Factor 5 Promotes De Novo Ceramide Biosynthesis and Contributes to Eccentric Remodeling in Ischemic Cardiomyopathy. Circulation, 143(11), 1139-1156.
  111. Cluntun AA, Badolia R, Lettlova S, Parnell KM, Shankar TS, Diakos NA, Olson KA, Taleb I, Tatum SM, Berg JA, Cunningham CN, Van Ry T, Bott AJ, Krokidi AT, Fogarty S, Skedros S, Swiatek WI, Yu X, Luo B, Merx S, Navankasattusas S, Cox JE, Ducker GS, Holland WL, McKellar SH, Rutter J, Drakos S (2021). The pyruvate-lactate axis modulates cardiac hypertrophy and heart failure. Cell metabolism, 33(3), 629-648.e10.
  112. Hydren JR, Gifford JR, Jarrett CL, Park SH, Shields KL, Broxterman RM, Kithas AC, Bisconti AV, Thurston TS, Ratchford SM, Wray DW, Stehlik J, Selzman CH, Drakos SG, Richardson R (2021). Vascular function in continuous-flow left ventricular assist device recipients: effect of a single pulsatility treatment session. American journal of physiology. Regulatory, integrative and comparative physiology, 320(4), R425-R437.
  113. Shah P, Psotka M, Taleb I, Alharethi R, Shams MA, Wever-Pinzon O, Yin M, Latta F, Stehlik J, Fang JC, Diao G, Singh R, Ijaz N, Kyriakopoulos CP, Zhu W, May CW, Cooper LB, Desai SS, Selzman CH, Kfoury AG, Drakos S (2021). Framework to Classify Reverse Cardiac Remodeling With Mechanical Circulatory Support: The Utah-Inova Stages. Circulation. Heart failure, 14(5), e007991.
  114. Carley AN, Maurya SK, Fasano M, Wang Y, Selzman CH, Drakos SG, Lewandowski E (2021). Short-Chain Fatty Acids Outpace Ketone Oxidation in the Failing Heart. Circulation, 143(18), 1797-1808.
  115. Lyu Y, Verma VK, Lee Y, Taleb I, Badolia R, Shankar TS, Kyriakopoulos CP, Selzman CH, Caine W, Alharethi R, Navankasattusas S, Seidel T, Drakos SG, Sachse F (2021). Remodeling of t-system and proteins underlying excitation-contraction coupling in aging versus failing human heart. NPJ aging and mechanisms of disease, 7(1), 16.
  116. Shankar TS, Ramadurai DKA, Steinhorst K, Sommakia S, Badolia R, Thodou Krokidi A, Calder D, Navankasattusas S, Sander P, Kwon OS, Aravamudhan A, Ling J, Dendorfer A, Xie C, Kwon O, Cheng EHY, Whitehead KJ, Gudermann T, Richardson RS, Sachse FB, Schredelseker J, Spitzer KW, Chaudhuri D, Drakos S (2021). Cardiac-specific deletion of voltage dependent anion channel 2 leads to dilated cardiomyopathy by altering calcium homeostasis. Nature communications, 12(1), 4583.
  117. Healy AH, Bowen M, McKellar SH, Koliopoulou A, Drakos SG, Selzman C (2021). Interleukin-1 Receptor Antagonism as Adjunct Therapy for Heart Failure Patients with Left Ventricular Assist Devices. ASAIO journal (American Society for Artificial Internal Organs, 67(8), e145-e147.
  118. Wohlfahrt P, Nativi-Nicolau J, Zhang M, Selzman CH, Greene T, Conte J, Biber JE, Hess R, Mondesir FL, Wever-Pinzon O, Drakos SG, Gilbert EM, Kemeyou L, LaSalle B, Steinberg BA, Shah RU, Fang JC, Spertus JA, Stehlik (2021). Quality of Life in Patients With Heart Failure With Recovered Ejection Fraction. JAMA cardiology, 6(8), 957-962.
  119. Kampaktsis PN, Tzani A, Doulamis IP, Moustakidis S, Drosou A, Diakos N, Drakos SG, Briasoulis (2021). State-of-the-art machine learning algorithms for the prediction of outcomes after contemporary heart transplantation: Results from the UNOS database. Clinical transplantation, 35(8), e14388.
  120. Rorris FP, Antonopoulos CN, Kyriakopoulos CP, Drakos SG, Charitos (2021). Implantable cardioverter defibrillators in left ventricular assist device patients: ¿ systematic review and meta-analysis. The Journal of heart and lung transplantation, 40(10), 1098-1106.
  121. Sankarankutty AC, Greiner J, Bragard J, Visker JR, Shankar TS, Kyriakopoulos CP, Drakos SG, Sachse F (2021). Etiology-Specific Remodeling in Ventricular Tissue of Heart Failure Patients and Its Implications for Computational Modeling of Electrical Conduction. Frontiers in physiology, 12, 730933.
  122. Kyriakopoulos CP, Horne BD, Sideris K, Taleb I, Griffin RJ, Sheffield E, Alharethi R, Hanff TC, Stehlik J, Selzman CH, Drakos S (2023). Left ventricular functional improvement appears to contribute to lower rates of device thrombosis in patients on durable mechanical circulatory support. The Journal of heart and lung transplantation, 42(7), 853-858.
  123. Hanff TC, Browne A, Dickey J, Gaines H, Harhay MO, Goodwin M, Selzman CH, Fang JC, Drakos SG, Stehlik (2023). Heart waitlist survival in adults with an intra-aortic balloon pump relative to other Status 2, Status 1, and inotrope Status 3 patients. The Journal of heart and lung transplantation, 42(3), 368-376.
  124. Browne A, Gaines H, Alharethi R, Goodwin M, Selzman CH, Fang JC, Drakos SG, Stehlik J, Hanff T (2023). Interrupted Time Series Analysis of Donor Heart Use Before and After the 2018 UNOS Heart Allocation Policy Change. Journal of cardiac failure, 29(2), 220-224.
  125. Marashly Q, Taleb I, Kyriakopoulos CP, Dranow E, Jones TL, Tandar A, Overton SD, Tonna JE, Stoddard K, Wever-Pinzon O, Kemeyou L, Koliopoulou AG, Shah KS, Nourian K, Richins TJ, Burnham TS, Welt FG, McKellar SH, Nativi-Nicolau J, Drakos S (2021). Predicting mortality in cardiogenic shock secondary to ACS requiring short-term mechanical circulatory support: The ACS-MCS score. Catheterization and cardiovascular interventions, 98(7), 1275-1284.
  126. Sommakia S, Almaw NH, Lee SH, Ramadurai DKA, Taleb I, Kyriakopoulos CP, Stubben CJ, Ling J, Campbell RA, Alharethi RA, Caine WT, Navankasattusas S, Hoareau GL, Abraham AE, Fang JC, Selzman CH, Drakos SG, Chaudhuri (2022). FGF21 (Fibroblast Growth Factor 21) Defines a Potential Cardiohepatic Signaling Circuit in End-Stage Heart Failure. Circulation. Heart failure, 15(3), e008910.
  127. Topkara VK, Sayer GT, Clerkin KJ, Wever-Pinzon O, Takeda K, Takayama H, Selzman CH, Naka Y, Burkhoff D, Stehlik J, Farr MA, Fang JC, Uriel N, Drakos S (2022). Recovery With Temporary Mechanical Circulatory Support While Waitlisted for Heart Transplantation. Journal of the American College of Cardiology, 79(9), 900-913.
  128. Balderas E, Eberhardt DR, Lee S, Pleinis JM, Sommakia S, Balynas AM, Yin X, Parker MC, Maguire CT, Cho S, Szulik MW, Bakhtina A, Bia RD, Friederich MW, Locke TM, Van Hove JLK, Drakos SG, Sancak Y, Tristani-Firouzi M, Franklin S, Rodan AR, Chaudhuri (2022). Mitochondrial calcium uniporter stabilization preserves energetic homeostasis during Complex I impairment. Nature communications, 13(1), 2769.
  129. Kapelios CJ, Lund LH, Wever-Pinzon O, Selzman CH, Myers SL, Cantor RS, Stehlik J, Chamogeorgakis T, McKellar SH, Koliopoulou A, Alharethi R, Kfoury AG, Bonios M, Adamopoulos S, Gilbert EM, Fang JC, Kirklin JK, Drakos S (2022). Right Heart Failure Following Left Ventricular Device Implantation: Natural History, Risk Factors, and Outcomes: An Analysis of the STS INTERMACS Database. Circulation. Heart failure, 15(6), e008706.
  130. Knox DB, Lanspa MJ, Wilson E, Haaland B, Beesley S, Hirshberg E, Abraham TP, Vallabhajosyula S, Grissom CK, Drakos SG, Brown S (2022). Initial Derivation of a Predictive Model for Left Ventricular Longitudinal Strain (LS) in Early Sepsis. Journal of intensive care medicine, 37(8), 1049-1054.
  131. Felker GM, Buttrick P, Rosenzweig A, Abel ED, Allen LA, Bristow M, Das S, DeVore AD, Drakos SG, Fang JC, Freedman JE, Hernandez AF, Li DY, McKinsey TA, Newton-Cheh C, Rogers JG, Shah RV, Shah SH, Stehlik J, Selzman C (2022). Heart Failure Strategically Focused Research Network: Summary of Results and Future Directions. Journal of the American Heart Association, 11(18), e025517.
  132. Jentzer JC, Baran DA, Kyle Bohman J, van Diepen S, Radosevich M, Yalamuri S, Rycus P, Drakos SG, Tonna J (2022). Cardiogenic shock severity and mortality in patients receiving venoarterial extracorporeal membrane oxygenator support. European heart journal. Acute cardiovascular care, 11(12), 891-903.
  133. Drakos SG, Badolia R, Makaju A, Kyriakopoulos CP, Wever-Pinzon O, Tracy CM, Bakhtina A, Bia R, Parnell T, Taleb I, Ramadurai DKA, Navankasattusas S, Dranow E, Hanff TC, Tseliou E, Shankar TS, Visker J, Hamouche R, Stauder EL, Caine WT, Alharethi R, Selzman CH, Franklin (2023). Distinct Transcriptomic and Proteomic Profile Specifies Patients Who Have Heart Failure With Potential of Myocardial Recovery on Mechanical Unloading and Circulatory Support. Circulation, 147(5), 409-424.
  134. Palatinus JA, Valdez S, Taylor L, Whisenant C, Selzman CH, Drakos SG, Ranjan R, Hong T, Saffitz JE, Shaw R (2023). GJA1-20k Rescues Cx43 Localization and Arrhythmias in Arrhythmogenic Cardiomyopathy. Circulation research, 132(6), 744-746.

Review

  1. Drakos SG, Terrovitis JV, Anastasiou-Nana MI, Nanas J (2007). Reverse remodeling during long-term mechanical unloading of the left ventricle. Journal of molecular and cellular cardiology, 43(3), 231-42.
  2. Drakos SG, Anastasiou-Nana MI, Malliaras KG, Nanas J (2009). Anemia in chronic heart failure. Congestive heart failure (Greenwich, Conn.), 15(2), 87-92.
  3. Wever-Pinzon O, Drakos SG, Fang J (2015). Team-based Care for Advanced Heart Failure. Heart failure clinics, 11(3), 467-77.
  4. Terrovitis JV, Anastasiou-Nana M, Kaldara E, Drakos SG, Nanas SN, Nanas J (2009). Anemia in heart failure: pathophysiologic insights and treatment options. Future cardiology, 5(1), 71-81.
  5. Hammond MEH, Stehlik J, Drakos SG, Kfoury A (2021). Bias in Medicine: Lessons Learned and Mitigation Strategies. JACC. Basic to translational science, 6(1), 78-85.
  6. Shah KS, Hale Hammond ME, Drakos SG, Anderson JL, Fang JC, Knowlton KU, Shaw R (2021). SARS-CoV-2 as an inflammatory cardiovascular disease: current knowledge and future challenges. Future cardiology, 17(7), 1277-1291.
  7. Tseliou E, Lavine KJ, Wever-Pinzon O, Topkara VK, Meyns B, Adachi I, Zimpfer D, Birks EJ, Burkhoff D, Drakos S (2022). Biology of myocardial recovery in advanced heart failure with long-term mechanical support. The Journal of heart and lung transplantation, 41(10), 1309-1323.
  8. Taleb I, Tseliou E, Fang JC, Drakos S (2022). A Mechanical Bridge to Recovery as a Bridge to Discovery: Learning From Few and Applying to Many. Circulation, 145(8), 562-564.
  9. Kyriakopoulos CP, Kapelios CJ, Stauder EL, Taleb I, Hamouche R, Sideris K, Koliopoulou AG, Bonios MJ, Drakos S (2022). LVAD as a Bridge to Remission from Advanced Heart Failure: Current Data and Opportunities for Improvement. Journal of clinical medicine, 11(12),
  10. Tehrani BN, Drakos SG, Billia F, Batchelor WB, Luk A, Stelling K, Tonna J, Rosner C, Hanff T, Rao V, Brozzi NA, Baran D (2022). The Multicenter Collaborative to Enhance Biologic Understanding, Quality, and Outcomes in Cardiogenic Shock (VANQUISH Shock): Rationale and Design. The Canadian journal of cardiology, 38(8), 1286-1295.
  11. Bonios MJ, Armenis I, Kogerakis N, Thodou A, Gkouziouta A, Koliopoulou A, Kaklamanis L, Chamogeorgakis T, Drakos SG, Adamopoulos S (2022). Phenotype Characterization and Course of Patients With Arrhythmogenic Right Ventricular Cardiomyopathy and Biventricular Advanced Heart Failure: A Report of 3 Cases. Transplantation proceedings, 54(8), 2347-2351.

Book Chapter

  1. Drakos SG, Alexopoulos G, Nanas J (2005). Organizing a heart failure program. In Filippatos G, Adamopoulos S, Parissis J, Anthopoulos L, Kremastinos D (Eds.), Heart Failure: from diagnosis to treatment (pp. 453-464). Athens, Greece: Paschalides Editions.
  2. Tsagalou EP, Drakos SG, Tsolakis E, Nanas (2008). Intra-aortic balloon pump in the management of acute heart failure syndromes. In Alexandre Mebazaa, Mihai Gheorghiade, Faiez Zannad, Joseph Parrillo (Eds.), Acute Heart Failure (pp. 671-684). New York, NY: Springer.
  3. Terrovitis JV, Tseliou E, Drakos SG, Nanas J (2011). Evaluation of Cardiac Function after VAD Implantation, New Aspects of Ventricular Assist Devices, Guillermo Reyes (Ed.), ISBN: 978-953-307-676-8, InTech, Available from : http://www.intechopen.com/books.
  4. Diakos NA, Wever-Pinzon O, Zannas AS, Drakos S (2013). Mechanical unloading and heart remodeling features. In Edmo Gabriel, Sthefano Gabriel (Eds.), Inflammatory response in cardiovascular surgery, New York, NY: Springer.

Conference Proceedings

  1. Bonios M, Drakos SG, Anastasiou-Nana M, Tsagalou E, Ntalianis A, Maroulidis G, Venetsanakos J, Lazaris N, Kanakakis J, Nanas (2007). Prognosis of Post-Myocardial Infarction Cardiogenic Shock Patients that Require Mechanical Ventilation. (indexed in Current Contents of ISI, Philadelphia, USA). XV, 383-7.
  2. Drakos SG, Bonios M, Terrovitis JV, Panagiotopoulos G, Pozios I, Diakos N, Tseliou E, Malliaras K, Kanakakis J, Anastasiou-Nana M (2009). Commonly used risk factors failed to accurately predict survival in patients with advanced heart failure. (Indexed in Current Contents of ISI, Philadelphia, USA). 251.

Editorial

  1. Drakos SG, Mehra M (2016). Clinical myocardial recovery during long-term mechanical support in advanced heart failure: Insights into moving the field forward. The Journal of heart and lung transplantation, 35(4), 413-20.
  2. Uriel N, Drakos S (2015). Spotlight on new therapies in heart failure. Current opinion in cardiology, 30(3), 246-9.
  3. Drakos SG, Uriel (2014). Spotlight on cardiogenic shock therapies in the era of mechanical circulatory support. Current opinion in cardiology, 29(3), 241-3.
  4. Shah RU, Stehlik J, Drakos SG, Fang J (2015). Administrative data: proceed with caution. Journal of the American College of Cardiology, 65(10), 1063.
  5. Drakos SG (2014). The Odyssey of Chronic Cardiac Mechanical Support. Journal of the American College of Cardiology, Feb 27,
  6. Drakos S (2014). The odyssey of chronic cardiac mechanical support. Journal of the American College of Cardiology, 63(17), 1758-60.
  7. Hydren JR, Richardson RS, Wever-Pinzon O, Drakos S (2020). The "double whammy" of a continuous-flow left ventricular assist device on von Willebrand factor. The Journal of thoracic and cardiovascular surgery, 159(3), 910-915.
  8. Drakos SG, Pagani FD, Lundberg MS, Baldwin T (2017). Advancing the science of myocardial recovery with mechanical circulatory support: A Working Group of the National, Heart, Lung, and Blood Institute. The Journal of thoracic and cardiovascular surgery, 154(1), 165-170.
  9. Bonios MJ, Tseliou E, Drakos S (2021). Commentary: Major lessons from minor people: Beta blockers and cytokinesis in tetralogy of Fallot. The Journal of thoracic and cardiovascular surgery, 161(5), 1592-1593.
  10. Tandar A, Drakos S (2019). Cardiogenic shock in aortic stenosis patients: Balancing between complexity and simplicity. Hellenic journal of cardiology, 60(3), 182-184.
  11. Drakos S (2017). Combining Left Ventricular Volume Reduction Techniques With Cell Therapies: Quo Vadis?. Hellenic journal of cardiology, 58(2), 133-134.
  12. Bonios MJ, Adamopoulos SN, Drakos S (2020). Quality matters: Erectile dysfunction and cardiac resynchronization therapy. Hellenic journal of cardiology, 61(1), 40-41.
  13. Koliopoulou AG, Bonios MJ, Diakos NA, Drakos S (2020). Biventricular failure and total artificial heart: Old and new solutions for a vexing problem. Hellenic journal of cardiology, 61(6), 413-414.
  14. Kyriakopoulos CP, Taleb I, Drakos S (2022). Does cardiac recovery favorably impact adverse events and outcomes of LVAD patients?. The Journal of heart and lung transplantation, 41(8), 1029-1031.

Letter

  1. Taleb I, Koliopoulou AG, Tandar A, McKellar SH, Tonna JE, Nativi-Nicolau J, Alvarez Villela M, Welt F, Stehlik J, Gilbert EM, Wever-Pinzon O, Morshedzadeh JH, Dranow E, Selzman CH, Fang JC, Drakos S (2019). Shock Team Approach in Refractory Cardiogenic Shock Requiring Short-Term Mechanical Circulatory Support: A Proof of Concept. Circulation, 140(1), 98-100.
  2. Drakos SG, Anastasiou-Nana MI, Nanas J (2002). Exacerbation of variant angina by metoprolol resulting in syncope due to transient atrioventricular block. International journal of cardiology, 82(1), 83-5.
  3. Diakos NA, Selzman CH, Stehlik J, Sachse FB, Kfoury AG, Koliopoulou A, McKellar S, Fang JC, Li DY, Drakos S (2015). Reply: does size matter? In search of a physiological definition of myocardial atrophy. Journal of the American College of Cardiology, 65(19), 2156-7.
  4. Shah RU, Stehlik J, Drakos SG, Fang J (2015). Administrative data: proceed with caution. Journal of the American College of Cardiology, 65(10), 1063.
  5. Wever-Pinzon O, Kfoury AG, Selzman CH, Li DY, Stehlik J, Drakos S (2013). Reply: left ventricular assist devices in chronic heart failure: more questions than answers?. Journal of the American College of Cardiology, 62(23), 2257-8.
  6. Yin MY, Tandar A, Sharma V, Glotzbach JP, Shah RU, Dranow E, Tseliou E, Fang JC, Drakos SG, Welt FG (2020). Left Ventricular Hemodynamic Changes During Transcatheter Aortic Valve Replacement Assessed by Real-Time Pressure-Volume Loops. JACC. Cardiovascular interventions, 13(18), 2190-2192.
  7. Birks EJ, Rame JE, Cunningham C, Drakos S (2021). Response by Birks et al to Letters Regarding Article, "Prospective Multicenter Study of Myocardial Recovery Using Left Ventricular Assist Devices (RESTAGE-HF [Remission from Stage D Heart Failure]): Medium-Term and Primary End Point Results". Circulation, 143(22), e1017-e1018.
  8. Kapelios CJ, Drakos SG, Fang J (2022). Acute Decompensated Heart Failure, Volume, and Acetazolamide. The New England journal of medicine, 387(26), 2486.
  9. Pana TA, Savla J, Kepinski I, Fairbourn A, Afzal A, Mammen P, Drazner M, Subramaniam RM, Xing C, Morton KA, Drakos SG, Zaha VG, Sadek H (2022). Bidirectional Changes in Myocardial (18)F-Fluorodeoxyglucose Uptake After Human Ventricular Unloading. Circulation, 145(2), 151-154.

Other

  1. Jain P, Shehab S, Muthiah K, Robson D, Granegger M, Drakos SG, Jansz P, Macdonald PS, Hayward C (2019). Insights Into Myocardial Oxygen Consumption, Energetics, and Efficiency Under Left Ventricular Assist Device Support Using Noninvasive Pressure-Volume Loops. Circulation. Heart failure, 12(10), e006191.
  2. Balderas E, Eberhardt DR, Lee S, Pleinis JM, Sommakia S, Balynas AM, Yin X, Parker MC, Maguire CT, Cho S, Szulik MW, Bakhtina A, Bia RD, Friederich MW, Locke TM, Van Hove JLK, Drakos SG, Sancak Y, Tristani-Firouzi M, Franklin S, Rodan AR, Chaudhuri (2022). Author Correction: Mitochondrial calcium uniporter stabilization preserves energetic homeostasis during Complex I impairment. Nature communications, 13(1), 3532.
  3. Maron BA, Wang RS, Shevtsov S, Drakos SG, Arons E, Wever-Pinzon O, Huggins GS, Samokhin AO, Oldham WM, Aguib Y, Yacoub MH, Rowin EJ, Maron BJ, Maron MS, Loscalzo (2022). Author Correction: Individualized interactomes for network-based precision medicine in hypertrophic cardiomyopathy with implications for other clinical pathophenotypes. Nature communications, 13(1), 7026.

News & Podcasts

News

Podcasts